NCT06144333View on ClinicalTrials.gov

Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine

NANot yet recruitingINTERVENTIONAL

Enrollment

7,500

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

December 10, 2025

Study Completion Date

November 23, 2026

Conditions

SARS CoV 2 Infection

Interventions

DIAGNOSTIC_TEST

RIPH2

"* Blood sampling by capillary~* Swab sampling~* Blood sampling by venous punction~* Salivary sample, sputum, expectoration:"

All Listed Sponsors

lead

CerbaXpert

OTHER

NCT06144333 - Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine | Biotech Hunter | Biotech Hunter